| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| C4 Therapeutics, Inc. | Chief Scientific Officer | Common Stock | 130,710 | $831,316 | $6.36 | 16 Sep 2024 | Direct |
| C4 Therapeutics, Inc. | Chief Scientific Officer | Performance Restricted Stock Units | 14,250 | $90,630 | $6.36 | 16 Sep 2024 | Direct |
| C4 Therapeutics, Inc. | Chief Scientific Officer | Stock Option (Right to Buy) | 118,000 | 07 Mar 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CCCC | C4 Therapeutics, Inc. | 16 Sep 2024 | 3 | -$4,204 | 4 | Chief Scientific Officer | 17 Sep 2024, 17:12 |
| CCCC | C4 Therapeutics, Inc. | 07 Mar 2024 | 4 | $0 | 4 | Chief Scientific Officer | 08 Mar 2024, 19:26 |
| CCCC | C4 Therapeutics, Inc. | 13 Feb 2024 | 3 | -$14,725 | 4 | Chief Scientific Officer | 15 Feb 2024, 17:04 |
| CCCC | C4 Therapeutics, Inc. | 18 Sep 2023 | 1 | $0 | 4 | Chief Scientific Officer | 19 Sep 2023, 19:23 |
| CCCC | C4 Therapeutics, Inc. | 30 Aug 2023 | 3 | -$1,937 | 4 | Chief Scientific Officer | 31 Aug 2023, 16:10 |
| CCCC | C4 Therapeutics, Inc. | 13 Feb 2023 | 2 | $0 | 4 | Chief Scientific Officer | 15 Feb 2023, 15:46 |
| CCCC | C4 Therapeutics, Inc. | 30 Jan 2023 | 3 | -$10,122 | 4 | Chief Scientific Officer | 01 Feb 2023, 15:08 |
| CCCC | C4 Therapeutics, Inc. | 26 May 2022 | 1 | -$7,725 | 4/A | Chief Scientific Officer | 14 Jun 2022, 16:45 |
| CCCC | C4 Therapeutics, Inc. | 25 May 2022 | 2 | $0 | 4 | Chief Scientific Officer | 27 May 2022, 16:15 |
| CCCC | C4 Therapeutics, Inc. | 12 Apr 2022 | 4 | +$137,120 | 4 | Chief Scientific Officer | 12 Apr 2022, 20:41 |
| CCCC | C4 Therapeutics, Inc. | 14 Feb 2022 | 2 | $0 | 4 | Chief Scientific Officer | 16 Feb 2022, 15:30 |
| CCCC | C4 Therapeutics, Inc. | 08 Dec 2021 | 6 | +$73,000 | 4 | Chief Scientific Officer | 10 Dec 2021, 15:30 |
| CCCC | C4 Therapeutics, Inc. | 03 Aug 2021 | 1 | -$767,812 | 4 | Chief Scientific Officer | 05 Aug 2021, 19:34 |
| CCCC | C4 Therapeutics, Inc. | 29 Jul 2021 | 2 | -$3,074,387 | 4 | Chief Scientific Officer | 02 Aug 2021, 18:46 |